Incidence of lateral femoral cutaneous nerve lesions after direct anterior approach primary total hip arthroplasty - a literature review.

Direct anterior approach (DAA) Lateral femoral cutaneous nerve (LFCN) Minimal invasive hip replacement Review Total hip arthroplasty (THA)

Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
12 2021
Historique:
received: 12 05 2020
revised: 31 12 2020
accepted: 04 01 2021
pubmed: 8 5 2021
medline: 11 3 2022
entrez: 7 5 2021
Statut: ppublish

Résumé

Lesions of the lateral cutaneous femoral nerve are a reported complication of the direct anterior approach (DAA) for total hip arthroplasty (THA). Little is known about the incidence rates of this lesion. The goal of this study was to answer the following questions: (1) Is the true incidence rate of LFCN lesions after DAA THA known? (2) What are the reasons for the wide range of reported incidence rates in the literature? (3) Are surgeons increasingly aware of the significance of LFCN lesions? A US Medical Library of Medicine database search was performed for DAA THA. In total, 1261 search results were screened for reported LFCN lesions. Forty-five studies were included reporting LFCN lesions rates of 0-83%. Subgroup analysis for studies with (group A, 6 studies, n=1113 cases) and without (group B, 39 studies n=16,741) primary focus on the LFCN lesions was performed. Incidence in group A ranged from 14.8-81% (mean 31%) and 0-83% (mean 3.8%) in group B. The difference between the groups was significant (p=0.005). No uniform and time sensitive definition of postoperative LFCN lesions was found in the literature. An analysis of the publication year and the discovered incidence rate showed an increase of incidence rates [r Despite the absence of a uniform definition: LFCN lesions after DAA THA are a frequent and, in the past, often underestimated complication. IV; systematic review of level II to level IV studies.

Identifiants

pubmed: 33962046
pii: S1877-0568(21)00181-X
doi: 10.1016/j.otsr.2021.102956
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102956

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Falko Dahm (F)

II. Orthopedic Department, Orthopedic Hospital Speising, Speisinger Str. 109, 1130 Vienna, Austria; Division of Orthopedic Surgery, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Electronic address: f.dahm@gmx.net.

Alexander Aichmair (A)

II. Orthopedic Department, Orthopedic Hospital Speising, Speisinger Str. 109, 1130 Vienna, Austria; Michael Ogon Laboratory for Orthopedic Research, Orthopedic Hospital Speising, Speisinger Str. 109, 1130 Vienna, Austria.

Martin Dominkus (M)

II. Orthopedic Department, Orthopedic Hospital Speising, Speisinger Str. 109, 1130 Vienna, Austria; Sigmund Freud Medical University, Freudplatz 1, 1020 Vienna, Austria.

Jochen G Hofstaetter (JG)

II. Orthopedic Department, Orthopedic Hospital Speising, Speisinger Str. 109, 1130 Vienna, Austria; Michael Ogon Laboratory for Orthopedic Research, Orthopedic Hospital Speising, Speisinger Str. 109, 1130 Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH